Search - tctmd.com

Displaying 41 - 60 of 83

Sort: Relevancy | Date

Presentation TCT 2019

Keynote Lecture: A Vision for an Evolving Regulatory and Healthcare System

Presenter: Robert Califf

September 26, 2019

Presentation TCT 2019

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Presenter: Saibal Kar

September 26, 2019

Presentation TCT 2019

Keynote Lecture: New Technology Assessment and Reimbursement Synergy — Forward Strides

Presenter: Lori Ashby

September 26, 2019

Presentation TCT 2019

Keynote Lecture: FDA/CDRH — The Year in Review, Focus on CDRH’s Total Product Life Cycle Concept

Presenter: William Maisel

September 26, 2019

Presentation TCT 2019

COAPT, Partner 2, and Evolut Low-Risk Trial Synopsis and What They Mean Moving Forward

Presenter: Elizabeth Perpetua

September 25, 2019

Presentation TVT 2019

Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

Presenter: Mubashir Mumtaz

June 14, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Coronary Access Issues) – A Case-Based Discussion

Presenter: Stanley Chetcuti

June 13, 2019

Presentation TVT 2019

Latest Clinical Data in Bicuspid Disease

Presenter: John Forrest

June 13, 2019

Presentation TVT 2019

Imaging Implantation Tips and Tricks

Presenter: Nicolo Piazza

June 13, 2019

Presentation TVT 2019

Advanced Design Features and Future Vision

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot Study

Presenter: Gilbert Tang

June 13, 2019

Presentation TCT 2018

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

Presenter: Alexander Lauten

September 23, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Jeffrey J. Popma

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

Presenter: Michael J. Mack

June 21, 2018

Presentation JIM 2018

Evolut PRO latest innovation in TAVI: a workhorse device to treat all patient

Presenter: A. Sonia Petronio

February 22, 2018

Presentation TCT 2017

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Presenter: Hemal Gada

October 31, 2017

Presentation TCT 2017

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

Presenter: John K. Forrest

October 31, 2017

Presentation TCT 2017

The Evolut R Low-risk Trial

Presenter: Jeffrey J. Popma

October 30, 2017

Presentation TCT 2017

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Featured Lecture: Technological Evolution of Cath-lab Technologies: Impact of Advanced Imaging Diagnostics on Procedural Flow and Interventional Procedures

Presenter: Bernard De Bruyne, Evelyn S. Regar, Giora Weisz

October 30, 2017

Advertisement

Keynote Lecture: A Vision for an Evolving Regulatory and Healthcare System

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Keynote Lecture: New Technology Assessment and Reimbursement Synergy — Forward Strides

Keynote Lecture: FDA/CDRH — The Year in Review, Focus on CDRH’s Total Product Life Cycle Concept

COAPT, Partner 2, and Evolut Low-Risk Trial Synopsis and What They Mean Moving Forward

Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Coronary Access Issues) – A Case-Based Discussion

Latest Clinical Data in Bicuspid Disease

Imaging Implantation Tips and Tricks

Advanced Design Features and Future Vision

Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot Study

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

Evolut PRO latest innovation in TAVI: a workhorse device to treat all patient

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

The Evolut R Low-risk Trial

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Featured Lecture: Technological Evolution of Cath-lab Technologies: Impact of Advanced Imaging Diagnostics on Procedural Flow and Interventional Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content